Development and validity testing of the neuropathy total symptom score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy*
References (60)
- et al.
Complaints of neuropathy related to the clinical and neurophysiological assessment of nerve function in patients with diabetes mellitus
Diabetes Res Clin Pract
(1994) - et al.
Graphic representation of pain
Pain
(1976) - et al.
Venlafaxine extended release in the treatment of painful diabetic neuropathy: A double-blind, placebo-controlled study
Pain
(2004) - et al.
Duloxetine vs placebo in patients with painful diabetic neuropathy
Pain
(2005) The McGill Pain Questionnaire: Major properties and scoring methods
Pain
(1975)- et al.
Quality of life of women with urinary incontinence: Further development of the incontinence quality of life instrument (I-QOL)
Urology
(1999) - et al.
Evaluating quality-of-life and health status instruments: Development of scientific review criteria
Clin Ther
(1996) - et al.
A novel approach to the diagnosis and assessment of symptomatic diabetic neuropathy
Pain
(1989) - et al.
Painful diabetic polyneuropathy: Epidemiology, pain description, and quality of life
Diabetes Res Clin Pract
(2000) - et al.
The development of a questionnaire to measure the severity of symptoms and the quality of life before and after surgery for stress incontinence
BJOG
(2003)
Quality-of-life questionnaire for patients taking antihypertensive medication
Clin Ther
(1999)
Methods to explain the clinical significance of health status measures
Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial
Clin Ther
(2005)
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study
Neurology
(1993)
Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: The EURODIAB IDDM Complications Study
Diabetologia
(1996)
Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study
Diabetes
(1989)
A multicenter study on the prevalence of diabetic neuropathy in Italy
Diabetes Care
(1997)
A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population
Diabetologia
(1993)
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials
J Neurol Sci
(2001)
Diabetic somatic neuropathies
Diabetes Care
(2004)
Symptoms of sensory neuropathy in adults with NIDDM in the US population
Diabetes Care
(1993)
The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population
Diabetes Care
(1985)
Pain in diabetic neuropathy case study: Whole patient management
Eur J Neurol
(2004)
Prevalence and forms of neuropathic morbidity in 800 diabetics
Jr J Med Sci
(1994)
Neuropathy in non-insulin-dependent diabetes mellitus. The significance of symptoms
Scand J Prim Health Care
(1998)
Standards of medical care in diabetes (Position Statement)
Diabetes Care
(2005)
Neuropathy Total Symptom Score-6 Questionnaire (NTSS-6) is a valid instrument for assessing the positive symptoms of diabetic peripheral neuropathy (DPN)
Diabetes
(2002)
Electronic case-report forms of symptoms and impairments of peripheral neuropathy
Can J Neurol Sci
(2002)
Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial
JAMA
(1998)
Cited by (158)
A smartphone-based tool for screening diabetic neuropathies: A mHealth and 3D printing approach
2024, Biomedical Signal Processing and ControlNeuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation Survivors
2022, Transplantation and Cellular TherapyScreening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations
2022, Diabetes Research and Clinical PracticeMast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy
2022, Annals of Allergy, Asthma and ImmunologyCitation Excerpt :For all patients in the HαT and MCAS groups, validated neurologic symptom surveys were completed at the time of autonomic testing. Sensory complaints were surveyed by the Neuropathy Total Symptom Score—6 (NTSS) which is a validated instrument for evaluation of pain features.13 NTSS quantifies sensory symptoms (aching pain, allodynia, burning pain, lancinating pain, numbness, and prickling sensation).
- *
Express Track online publication August 16, 2005.
- *
All MBBQ Study Group principal investigators and sites are listed in the Acknowledgments.
Copyright © 2005 Published by Elsevier Inc.